Insider · CIK 0001537529
Brett P Monia
ceoofficerdirector
Files at IONS (IONIS PHARMACEUTICALS INC), CGTX (COGNITION THERAPEUTICS INC). First filing Nov 14, 2024, latest Sep 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $15M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
IONSOct 9, 2026 · close 45.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | IONIS PHARMACEUTICALS INC | $12M 203,814 shares | -72% | +137% from low0% from high | |
| 15Weak | IONIS PHARMACEUTICALS INC | $109k 2,432 shares | -1% | +70% from low-1% from high | |
| 12Weak | IONIS PHARMACEUTICALS INC | $48k 1,160 shares | -1% | +64% from low-4% from high | |
| 5Weak | IONIS PHARMACEUTICALS INC | $4,525 140 shares | -0% | - | |
| 50Moderate | IONIS PHARMACEUTICALS INC | $1.2M 38,843 shares | -18% | - | |
| 57Moderate | IONIS PHARMACEUTICALS INC | $430k 13,242 shares | -6% | - | |
| 55Moderate | IONIS PHARMACEUTICALS INC | $1.1M 33,445 shares | -14% | - | |
| 33Weak | IONIS PHARMACEUTICALS INC | $252k 6,630 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +98 | $51.31 | $5,028 | 242,760 | 40 d ago |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +102,900 | $53.77 | $5.5M | 282,909 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -16,615 | $59.12 | $982k | 266,294 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +42,030 | $37.58 | $1.6M | 308,324 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -127,500 | $60.13 | $7.7M | 180,824 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +31,316 | $32.60 | $1.0M | 212,140 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +27,568 | $32.60 | $899k | 239,708 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -59,699 | $61.06 | $3.6M | 180,009 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -31,316 | $0.00 | $0 | 67,741 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -27,568 | $0.00 | $0 | 40,173 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -42,030 | $0.00 | $0 | 76,643 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -102,900 | $0.00 | $0 | 0 | Sep 4, 2025 |
| Aug 29, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +189 | $27.71 | $5,237 | 180,009 | Sep 3, 2025 |
| Jul 30, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +2,432 | $32.60 | $79k | 182,252 | Aug 1, 2025 |
| Jul 30, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -2,432 | $45.00 | $109k | 179,820 | Aug 1, 2025 |
| Jul 30, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,432 | $0.00 | $0 | 99,057 | Aug 1, 2025 |
| Jul 11, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,160 | $41.74 | $48k | 179,820 | Jul 15, 2025 |
| Jun 18, 2025 | CGTX COGNITION THERAPEUTICS INC | AGrant or award Common Stock | +34,000 | $0.00 | $0 | 48,500 | Jun 23, 2025 |
| Mar 11, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -140 | $32.32 | $4,525 | 180,980 | Mar 13, 2025 |
| Feb 28, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +437 | $28.21 | $12k | 181,120 | Mar 4, 2025 |
| Feb 4, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -38,843 | $31.65 | $1.2M | 180,683 | Feb 6, 2025 |
| Jan 30, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Common Stock | +25,372 | $0.00 | $0 | 232,768 | Feb 3, 2025 |
| Jan 31, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -13,242 | $32.45 | $430k | 219,526 | Feb 3, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +73,448 | $0.00 | $0 | 240,841 | Jan 17, 2025 |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -33,445 | $32.63 | $1.1M | 207,396 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Performance Restricted Stock Unitsderivative | +169,950 | $0.00 | $0 | 630,201 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +129,395 | $0.00 | $0 | 325,607 | Jan 17, 2025 |
| Jan 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -73,448 | $0.00 | $0 | 252,159 | Jan 17, 2025 |
| Jan 2, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +86,263 | $0.00 | $0 | 86,263 | Jan 6, 2025 |
| Nov 12, 2024 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -6,630 | $38.05 | $252k | 167,393 | Nov 14, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.